Paper29348462
Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1.
Hang W and 13 others. Oncogene, 2018. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1. Papers, record 29348462. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29348462
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Squamous Cell | Major topic |
| Dioxolanes | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Glutathione S-Transferase pi | Major topic |
| Head and Neck Neoplasms | Major topic |
| Quinuclidines | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Animals | |
| Apoptosis | |
| Biomarkers, Tumor | |
| Case-Control Studies | |
| Cell Proliferation | |
| Drug Therapy, Combination | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Mice | |
| Mice, SCID | |
| Prognosis | |
| Tumor Cells, Cultured | |
| Xenograft Model Antitumor Assays | |
| Piperidones |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA133053 | NCI NIH HHS | United States | R01CA133053 | PubMed and NIH |
Source NIH RePORTER
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27888811 | The role of p53 in cancer drug resistance and targeted chemotherapy. | Oncotarget | 2017 | https://conductscience.org/library/papers/27888811 | PubMed |
| 2 | 26905788 | Using Sensors and Generators of H2O2 to Elucidate the Toxicity Mechanism of Piperlongumine and Phenethyl Isothiocyanate. | Antioxid Redox Signal | 2016 | https://conductscience.org/library/papers/26905788 | PubMed |
| 3 | 24091667 | Piperlongumine induces autophagy by targeting p38 signaling. | Cell Death Dis | 2013 | https://conductscience.org/library/papers/24091667 | PubMed |
| 4 | 26975633 | APR-246 (PRIMA-1(MET)) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines. | Cancer Lett | 2016 | https://conductscience.org/library/papers/26975633 | PubMed |
| 5 | 24768524 | Mutant p53 reactivation by small molecules makes its way to the clinic. | FEBS Lett | 2014 | https://conductscience.org/library/papers/24768524 | PubMed |
| 6 | 23238172 | Overview of the therapeutic potential of piplartine (piperlongumine). | Eur J Pharm Sci | 2013 | https://conductscience.org/library/papers/23238172 | PubMed |
| 7 | 26848023 | Piperlongumine exerts cytotoxic effects against cancer cells with mutant p53 proteins at least in part by restoring the biological functions of the tumor suppressor. | Int J Oncol | 2016 | https://conductscience.org/library/papers/26848023 | PubMed |
| 8 | 27008382 | Vitamin E, γ-tocotrienol, Protects Against Buthionine Sulfoximine-Induced Cell Death by Scavenging Free Radicals in SH-SY5Y Neuroblastoma Cells. | Nutr Cancer | 2016 | https://conductscience.org/library/papers/27008382 | PubMed |
| 9 | 25767602 | Induction of BCL2-Interacting Killer, BIK, is Mediated for Anti-Cancer Activity of Curcumin in Human Head and Neck Squamous Cell Carcinoma Cells. | J Cancer | 2015 | https://conductscience.org/library/papers/25767602 | PubMed |
| 10 | 18035380 | Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer. | Mutat Res | 2008 | https://conductscience.org/library/papers/18035380 | PubMed |
| 11 | 27461609 | Antileukemic effects of piperlongumine and alpha lipoic acid combination on Jurkat, MEC1 and NB4 cells in vitro. | J Cancer Res Ther | 2016 | https://conductscience.org/library/papers/27461609 | PubMed |
| 12 | 24857548 | Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation. | Mol Cell | 2014 | https://conductscience.org/library/papers/24857548 | PubMed |
| 13 | 16420250 | Inhibitory effect of piperlonguminine on melanin production in melanoma B16 cell line by downregulation of tyrosinase expression. | Pigment Cell Res | 2006 | https://conductscience.org/library/papers/16420250 | PubMed |
| 14 | 27960087 | Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors. | Cancer Cell | 2016 | https://conductscience.org/library/papers/27960087 | PubMed |
| 15 | 24406211 | The role of reactive oxygen species and metabolism on cancer cells and their microenvironment. | Semin Cancer Biol | 2014 | https://conductscience.org/library/papers/24406211 | PubMed |
| 16 | 11875500 | Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound. | Nat Med | 2002 | https://conductscience.org/library/papers/11875500 | PubMed |
| 17 | 28439094 | Selective Targeting of Cancer Cells by Oxidative Vulnerabilities with Novel Curcumin Analogs. | Sci Rep | 2017 | https://conductscience.org/library/papers/28439094 | PubMed |
| 18 | 26963494 | Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer. | Cancer Lett | 2016 | https://conductscience.org/library/papers/26963494 | PubMed |
| 19 | 28160777 | Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species. | BMC Cancer | 2017 | https://conductscience.org/library/papers/28160777 | PubMed |
| 20 | 23355677 | Impaired epithelial differentiation of induced pluripotent stem cells from ectodermal dysplasia-related patients is rescued by the small compound APR-246/PRIMA-1MET. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23355677 | PubMed |
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939551 | Advances in p53 Therapies for Oral Squamous Cell Carcinoma: A Literature Review. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42939551 | PubMed |
| 40775425 | Network-based approach identifies key genes associated with tumor heterogeneity in HPV positive and negative head and neck cancer patients. | Sci Rep | 2025 | https://conductscience.org/library/papers/40775425 | PubMed |
| 40426992 | Strategies for Anticancer Treatment in p53-Mutated Head and Neck Squamous Cell Carcinoma. | Biomedicines | 2025 | https://conductscience.org/library/papers/40426992 | PubMed |
| 39697540 | Combination of Vitex pseudo-negundo methanolic-extract with cisplatin can induce antioxidant activity and apoptosis in HeLa and Caski cells. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39697540 | PubMed |
| 38275623 | PTC596-Induced BMI-1 Inhibition Fights Neuroblastoma Multidrug Resistance by Inducing Ferroptosis. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/38275623 | PubMed |
| 37736748 | Oral squamous cell carcinomas: state of the field and emerging directions. | Int J Oral Sci | 2023 | https://conductscience.org/library/papers/37736748 | PubMed |
| 37608128 | Reconstructing the immunosenescence core pathway reveals global characteristics in pan-cancer. | Cancer Immunol Immunother | 2023 | https://conductscience.org/library/papers/37608128 | PubMed |
| 37049976 | Compound 275# Induces Mitochondria-Mediated Apoptosis and Autophagy Initiation in Colorectal Cancer Cells through an Accumulation of Intracellular ROS. | Molecules | 2023 | https://conductscience.org/library/papers/37049976 | PubMed |
| 36046754 | The promising potential of piperlongumine as an emerging therapeutics for cancer. | Explor Target Antitumor Ther | 2021 | https://conductscience.org/library/papers/36046754 | PubMed |
| 35071005 | Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments. | Front Oncol | 2021 | https://conductscience.org/library/papers/35071005 | PubMed |
| 34229670 | Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage. | BMC Complement Med Ther | 2021 | https://conductscience.org/library/papers/34229670 | PubMed |
| 34047948 | Kuanxiong Aerosol () in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology. | Chin J Integr Med | 2021 | https://conductscience.org/library/papers/34047948 | PubMed |
| 33946704 | Glutathione S-Transferases in Cancer. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/33946704 | PubMed |
| 33371351 | STAT3 and p53: Dual Target for Cancer Therapy. | Biomedicines | 2020 | https://conductscience.org/library/papers/33371351 | PubMed |
| 33314700 | A thiol-bound drug reservoir enhances APR-246-induced mutant p53 tumor cell death. | EMBO Mol Med | 2021 | https://conductscience.org/library/papers/33314700 | PubMed |
| 33023080 | The Application of Next-Generation Sequencing to Define Factors Related to Oral Cancer and Discover Novel Biomarkers. | Life (Basel) | 2020 | https://conductscience.org/library/papers/33023080 | PubMed |
| 31739520 | Piperlongumine Induces Cell Cycle Arrest via Reactive Oxygen Species Accumulation and IKKβ Suppression in Human Breast Cancer Cells. | Antioxidants (Basel) | 2019 | https://conductscience.org/library/papers/31739520 | PubMed |
| 31680961 | Piperlongumine Inhibits Akt Phosphorylation to Reverse Resistance to Cisplatin in Human Non-Small Cell Lung Cancer Cells via ROS Regulation. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31680961 | PubMed |
| 31493144 | Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells. | Cell Oncol (Dordr) | 2019 | https://conductscience.org/library/papers/31493144 | PubMed |
| 31334116 | Ruthenium Complexes With Piplartine Cause Apoptosis Through MAPK Signaling by a p53-Dependent Pathway in Human Colon Carcinoma Cells and Inhibit Tumor Development in a Xenograft Model. | Front Oncol | 2019 | https://conductscience.org/library/papers/31334116 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29348462
GET https://conductscience.org/api/papers/v1/29348462/references?page=2